Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AF
- Chemical substanceJ05AF04Stavudine
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 14 medicines
- Stavudine1MG/ML · for solution · Cipla LTD
- Zerit1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · for solution · Bristol
- Zerit15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … · capsule · Bristol
- Zerit XR100MG, 37.5MG, 50MG … · capsule, extended release · Bristol Myers Squibb
Canada



